CUV 1.41% $13.96 clinuvel pharmaceuticals limited

Ann: Appendix 4E and Annual Report 2022, page-10

  1. 1,969 Posts.
    lightbulb Created with Sketch. 158
    NPAT is just accounting opinion and easily manipulated
    As evident by Clinuvel results
    The market does not care NPAT fell this year because of above

    EBIT much better
    Cash flow even better
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$13.96
Change
-0.200(1.41%)
Mkt cap ! $699.0M
Open High Low Value Volume
$14.20 $14.24 $13.88 $631.9K 44.90K

Buyers (Bids)

No. Vol. Price($)
1 416 $13.96
 

Sellers (Offers)

Price($) Vol. No.
$14.04 192 1
View Market Depth
Last trade - 16.10pm 15/08/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.